CITI Program has compiled these resources to help the research community prepare for and manage the challenges presented by the outbreak of COVID-19. Visit this page often as we will update this list with new resources as they become available along with important news, including significant changes, regulatory updates, and guidance.


CITI Program Webinar Recordings

We are temporarily providing these webinars as complimentary resources to help organizations and individuals with important topics presented by the current COVID-19 emergency. Check back for additional COVID-19 related webinars coming soon.

“Nuts & Bolts” of Running a Virtual IRB Meeting
Identifies strategies for running an IRB meeting in a virtual environment

 

FERPA and Online Learning in the Time of COVID-19
Explores how FERPA applies to online learning.

 

COVID-19 and Human Research Protection Programs
An in-depth discussion on how one institution and its HRPP responded to the COVID-19 pandemic.

 

Supporting Ethical Care and Responding to Workforce Concerns in a Public Health Emergency
Discusses public health duties during a public health emergency.


Government Resources

Institutional Review Board (IRB) Review of Individual Patient Expanded Access Requests for Investigational Drugs and Biological Products During the COVID-19 Public Health Emergency Guidance for IRBs and Clinical Investigators
U.S. Food & Drug Administration

Coronavirus (COVID-19) Resources
National Institutes of Health

Control and Prevention
United States Department of Labor – Occupational Safety and Health Administration

Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients of NIH Funding
National Institutes of Health – Grants & Funding

NIH clinical trial of investigational vaccine for COVID-19 begins
National Institutes of Health

FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic
U.S. Food & Drug Administration

Notification of Enforcement Discretion for Telehealth Remote Communications During the COVID-19 Nationwide Public Health Emergency
U.S. Department of Health & Human Services

Interim Guidance for Patients on Clinical Trials Supported by the NCI Cancer Therapy Evaluation Program and the NCI Community Oncology Research Program (NCORP)
U.S. Department of Health & Human Services

COVID-19 Pandemic Response Resources and FAQs for Animal Care and Use Programs
National Institutes of Health – Office of Laboratory Animal Welfare

COVID-19 Pandemic Response Resources and FAQs for Animal Care and Use Programs
National Institutes of Health – Office of Laboratory Animal Welfare
 

Contacts for Medical Devices During the COVID-19 Pandemic
U.S. Food & Drug Administration

Management of clinical trials during the COVID-19 pandemic: Notice to clinical trial sponsors
Government of Canada


CITI Program Articles

Time to revisit your disaster plan?

Preparing for COVID-19, Impacts on Research Organizations

U.S. Federal Regulatory Agencies Provide Guidance for Clinical Trials in Response to COVID-19


University Pages

Coronavirus Resource Center
Johns Hopkins University and Medicine

Human Subjects Protections Considerations
University of Kentucky – Office of Research Integrity

Decision Flow Chart for Pausing Studies (PDF)
University of Kentucky – Office of Research Integrity

COVID-19 and Urgent Research Tasks
Columbia University – Office of the Provost


Other Resources

COVID-19 Information
HRP Consulting Group

The Coronavirus Explained & What You Should Do
Kurzgesagt – In a Nutshell

Coronavirus disease (COVID-19) Pandemic
World Health Organization

COVID-19 Treatment and Vaccine Tracker
Milken Institute

Expanded Access to Convalescent Plasma for the Treatment of Patients With COVID-19
Mayo Clinic

The global impact of COVID-19 on clinical trials and countermeasure development
Hogan Lovell – Engage

Research in global health emergencies
Nuffield Council on Bioethics

Every Vaccine and Treatment in Development for COVID-19, So Far
Visual Capitalist

Suggested Best Practices for ClinicalTrials.gov Activity during the COVID-19 Pandemic
Clinical Trials Registration and Results Reporting Taskforce


Prospective Research Subjects

Please download our complimentary resource for those considering participation in research or clinical trials. This resource covers subject’s rights, questions that should be asked about the study, informed consent, and definitions of commonly used terms.

Download Are You Thinking About Being in a Research Study?


Do you have an idea for a resource?

Resource suggestions will provide CITI Program with a way to stay atop of what is important to the research community during the COVID-19 outbreak. We value your opinions and invite you to submit a resource, resource ideas, or your organization’s best practices for inclusion on our COVID-19 resources page.

Submit Your Resource Idea